Ginkgo Bioworks Holdings Inc (NYSE: DNA) kicked off on Friday, down -6.46% from the previous trading day, before settling in for the closing price of $0.92. Over the past 52 weeks, DNA has traded in a range of $0.85-$2.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 104.75%. While this was happening, its average annual earnings per share was recorded 30.43%. With a float of $1.35 billion, this company’s outstanding shares have now reached $1.53 billion.
Let’s determine the extent of company efficiency that accounts for 1218 employees.
Ginkgo Bioworks Holdings Inc (DNA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ginkgo Bioworks Holdings Inc is 33.65%, while institutional ownership is 61.11%. The most recent insider transaction that took place on Apr 02 ’24, was worth 53,727. In this transaction an insider of this company sold 51,169 shares at a rate of $1.05, taking the stock ownership to the 865,079 shares. Before that another transaction happened on Mar 04 ’24, when Company’s insider sold 38,826 for $1.26, making the entire transaction worth $48,765. This insider now owns 808,125 shares in total.
Ginkgo Bioworks Holdings Inc (DNA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.43% per share during the next fiscal year.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators
Take a look at Ginkgo Bioworks Holdings Inc’s (DNA) current performance indicators. Last quarter, stock had a quick ratio of 6.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)
Looking closely at Ginkgo Bioworks Holdings Inc (NYSE: DNA), its last 5-days average volume was 39.23 million, which is a jump from its year-to-date volume of 23.52 million. As of the previous 9 days, the stock’s Stochastic %D was 10.89%. Additionally, its Average True Range was 0.09.
During the past 100 days, Ginkgo Bioworks Holdings Inc’s (DNA) raw stochastic average was set at 1.45%, which indicates a significant decrease from 4.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.73% in the past 14 days, which was lower than the 82.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1947, while its 200-day Moving Average is $1.5653. However, in the short run, Ginkgo Bioworks Holdings Inc’s stock first resistance to watch stands at $0.9187. Second resistance stands at $0.9726. The third major resistance level sits at $1.0064. If the price goes on to break the first support level at $0.8310, it is likely to go to the next support level at $0.7972. Now, if the price goes above the second support level, the third support stands at $0.7433.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Key Stats
The company with the Market Capitalisation of 1.76 billion has total of 2,152,396K Shares Outstanding. Its annual sales at the moment are 251,460 K in contrast with the sum of -892,870 K annual income. Company’s last quarter sales were recorded 34,750 K and last quarter income was -211,690 K.
